Get the app!
Back to Trades
Total Value
$34.2K
Net $34.2K sold
Filing Date
Oct 28, 2025
2 transactions
Sales
$34.2K
2 transactions

Trade Summary

On Oct 24, 2025 through Oct 27, 2025, Pham Quang X, CEO and Chairman, Director, 10% Owner, sold $34.2K of Cadrenal Therapeutics, Inc. (CVKD) across 2 transactions. The filing covers Common Stock and reflects net selling of $34.2K. Reported prices ranged from $13.99 to $14.03. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.

Company Information

Ticker Symbol
CVKD
CIK
0001937993

Insider Information

Role
CEO and Chairman, Director, 10% Owner
Location
PONTE VEDRA,, FL

Filing Details

Filing Date
Oct 28, 2025
Transaction Date
Oct 24, 2025
Accession Number
0001213900-25-103146
Form Type
4
Net Trading Amount
-$34.2K

Non-Derivative Transactions

DateSecuritySharesPriceTypeValue
Oct 24, 2025Common Stock1,129$14.03Sale$15.8K
Oct 27, 2025Common Stock1,315$13.99Sale$18.4K

Want live alerts when Pham Quang X trades again?

Download Insider Trades to track CVKD, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.

Footnotes

  1. (F1)Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement adopted by the Reporting Person on May 9, 2025.
  2. (F2)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.99 through $14.10. The Reporting Person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  3. (F3)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.99 through $14.00. The Reporting Person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  4. (F4)Quang Pham is the Trustee of The PVBQ Living Trust and has sole voting and disposition power with respect to the shares owned by The PVBQ Trust, of which Mr. Pham's child is the sole beneficiary.

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.